Tumor Biology

, Volume 37, Issue 7, pp 9139–9149 | Cite as

Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India

  • Soumee Ghosh
  • Sudakshina Ghosh
  • Biswabandhu Bankura
  • Makhan Lal Saha
  • Suvendu Maji
  • Souvik Ghatak
  • Arup Kumar Pattanayak
  • Susanta Sadhukhan
  • Manalee Guha
  • Senthil Kumar Nachimuthu
  • Chinmay Kumar Panda
  • Biswanath Maity
  • Madhusudan Das
Original Article


Gastric cancer is one of the most common malignancies in India. DNA repair gene or xenobiotic pathway gene polymorphisms have recently been shown to affect individual susceptibility to gastric cancer. Here, the possible interaction between common polymorphisms in X-ray repair cross complementing group I (XRCC1) gene and glutathione S-transferase (GST) genes (GSTM1, GSTT1 and GSTP1), smoking and alcohol consumption and overall survival in gastric cancer patients were evaluated. In this population-based case control study, 70 gastric cancer patients and 82 healthy controls were enrolled. The epidemiological data were collected by a standard questionnaire, and blood samples were collected from each individual. XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphisms were determined by polymerase chain reaction and direct DNA sequencing. GSTM1 and GSTT1 null polymorphisms and GSTP1 Ile105Val polymorphism were identified by multiplex polymerase chain reaction and restriction fragment length polymorphism (RFLP), respectively. The risk of gastric cancer was significantly elevated in individuals with XRCC1 Arg/Gln +Gln/Gln (p = 0.031; odds ratio = 2.32; 95 % confidence interval (CI) 1.07–5.06) and GSTP1 Val/Val genotype (p = 0.009; odds ratio = 8.64; 95 % CI 1.84–40.55). An elevated risk for GC was observed in smokers and alcohol consumers carrying GSTP1 Ile/Val +Val/Val genotype (p = 0.041; odds ratio = 3.71; 95 % CI 0.98–14.12; p = 0.002; odds ratio = 12.31; 95 % CI 1.71–88.59). These findings suggest that XRCC1 rs25487 and GSTP1 rs1695 can be considered as a risk factor associated with gastric cancer and might be used as a molecular marker for evaluating the susceptibility of the disease.


Gastric cancer XRCC1 GSTP1 SNPs 



The work was supported by the Department of Biotechnology, Government of India [BT/360/NE/TBP/2012 DATE-25.03.2013, sanctioned to Prof. Madhusudan Das]

Compliance with ethical standards

Conflicts of interest


Supplementary material

13277_2015_4780_MOESM1_ESM.docx (13 kb)
Supplementary Table 1 (DOCX 12 kb)


  1. 1.
    Stewart BW, Wild CP, editors. World cancer report. Lyon: IARC; 2014.Google Scholar
  2. 2.
    Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010–2020) by cancer groups. Asian Pac J Cancer Prev. 2010;11:1045–9.PubMedGoogle Scholar
  3. 3.
    Zhao Y, Deng X, Song G, Qin S, Liu Z. The GSTM1 null genotype increased risk of gastric cancer: a meta-analysis based on 46 studies. PLoS One. 2013;8, e81403.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Liu BM, Liu TM, You BS, You HY, Yang J, Li L, et al. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis. Genet Mol Res. 2012;11:3852–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Palli D, Polidoro S, D’Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569–75.CrossRefPubMedGoogle Scholar
  7. 7.
    Yuan T, Deng S, Chen M, Chen W, Lu W, Huang H, et al. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol. 2011;35:170–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol. 1999;6:884–93.CrossRefPubMedGoogle Scholar
  9. 9.
    Qiao W, Wang T, Zhang L, Tang Q, Wang D, Sun H. Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population. Int J Biol Sci. 2013;9:753–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients. Anticancer Res. 2011;31:705–10.PubMedGoogle Scholar
  11. 11.
    García-González MA, Quintero E, Bujanda L, Nicolás D, Benito R, Strunk M, et al. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis. 2012;27:771–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.CrossRefPubMedGoogle Scholar
  14. 14.
    Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir valley. J Gastrointest Cancer. 2009;40:26–32.CrossRefPubMedGoogle Scholar
  15. 15.
    Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers. 2010;14:715–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Tripathi S, Ghoshal U, Mittal B, Chourasia D, Kumar S, Ghoshal UC. Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer. Indian J Gastroenterol. 2011;30:257–63.CrossRefPubMedGoogle Scholar
  17. 17.
    Khabaz MN. Polymorphism of the glutathione S-transferase P1 gene (GST-PI) in breast carcinoma. Pol J Pathol. 2014;65:141–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med. 2001;7:517–21.CrossRefPubMedGoogle Scholar
  19. 19.
    Schneider J, Classen V, Helmig S. XRCC1 polymorphism and lung cancer risk. Expert Rev Mol Diagn. 2008;8:761–80.CrossRefPubMedGoogle Scholar
  20. 20.
    Lee S-G, Kim B, Choi J, Kim C, Lee I, Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 2002;187:53–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000;88:601–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15:5716–21.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Zhang Y, Sun L-P, Xing C-Z, Xu Q, He C-Y, Li P, et al. Interaction between GSTP1 Val Allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population. Guan X-Y, editor. PLoS One. 2012; e47178.Google Scholar
  24. 24.
    Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions. Anticancer Res. 2011;31:1459–65.PubMedGoogle Scholar
  25. 25.
    Goekkurt E, Al-Batran S-E, Hartmann JT, Mogck U, Schuch G, Kramer M, et al. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. J Clin Oncol. 2009;27:2863–73.CrossRefPubMedGoogle Scholar
  26. 26.
    Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, et al. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci. 2010;101:1247–54.CrossRefPubMedGoogle Scholar
  27. 27.
    Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, Chourasia D, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMedGoogle Scholar
  29. 29.
    González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23:644–5.PubMedGoogle Scholar
  30. 30.
    National Family Health Survey (NFHS-3). 2005–06: India: volume I. Int. Inst. Popul. Sci. Macro Int. Mumbai; 2007.Google Scholar
  31. 31.
    Rannala B. Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics. 2001;1:203–21.CrossRefPubMedGoogle Scholar
  32. 32.
    Ratnasinghe LD, Abnet C, Qiao Y-L, Modali R, Stolzenberg-Solomon R, Dong Z-W, et al. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett. 2004;216:157–64.CrossRefPubMedGoogle Scholar
  33. 33.
    Jin E-H, Kim J, Lee S-I, Hong JH. Association between polymorphisms in APE1 and XRCC1 and the risk of gastric cancer in Korean population. Int J Clin Exp Med. 2015;8:11484–9.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus. 2009;22:396–401.CrossRefPubMedGoogle Scholar
  35. 35.
    Xue H, Ni P, Lin B, Xu H, Huang G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173:363–75.CrossRefPubMedGoogle Scholar
  36. 36.
    Duarte MC, Colombo J, Rossit ARB, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Pan X-F, Xie Y, Loh M, Yang S-J, Wen Y-Y, Tian Z, et al. Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case–control study. Asian Pac J Cancer Prev. 2012;13:5637–42.CrossRefPubMedGoogle Scholar
  38. 38.
    Wen Y-Y, Pan X-F, Loh M, Tian Z, Yang S-J, Lv S-H, et al. ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China. Asian Pac J Cancer Prev. 2012;13:2139–44.CrossRefPubMedGoogle Scholar
  39. 39.
    Zhao D-Y, Cheng L, Yu J, Shen H. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision. Cancer Biomark. 2014;14:449–56.CrossRefPubMedGoogle Scholar
  40. 40.
    Feng Y-Z, Liu Y-L, He X-F, Wei W, Shen X-L, Xie D-L. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case–control studies. Tumour Biol. 2014;35:10677–97.CrossRefPubMedGoogle Scholar
  41. 41.
    Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–71.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 1997;400:25–30.CrossRefPubMedGoogle Scholar
  43. 43.
    Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–71.CrossRefPubMedGoogle Scholar
  44. 44.
    Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R. Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population. Genet Mol Res. 2013;12:2567–77.CrossRefPubMedGoogle Scholar
  45. 45.
    Wu K, Su D, Lin K, Luo J, Au WW. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case–control studies. Asian Pac J Cancer Prev. 2011;12:2237–43.PubMedGoogle Scholar
  46. 46.
    Yan J, Wang X, Tao H, Deng Z, Yang W, Lin F. Meta-analysis of the relationship between XRCC1-Arg399Gln and Arg280His polymorphisms and the risk of prostate cancer. Sci Rep. 2015;5:9905.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Forat-Yazdi M, Gholi-Nataj M, Neamatzadeh H, Nourbakhsh P, Shaker-Ardakani H. Association of XRCC1 Arg399Gln polymorphism with colorectal cancer risk: a HuGE meta analysis of 35 studies. Asian Pac J Cancer Prev. 2015;16:3285–91.CrossRefPubMedGoogle Scholar
  48. 48.
    Chen L, Zhuo D, Chen J, Yuan H. XRCC1 polymorphisms and lung cancer risk in Caucasian populations: a meta-analysis. Int J Clin Exp Med. 2015;8:14969–76.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Qi Y, Cui L, Song Y, Li N. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Mol Biol Rep. 2014;41:879–87.CrossRefPubMedGoogle Scholar
  50. 50.
    Engin AB, Karahalil B, Karakaya AE, Engin A. Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol. 2011;62:207–14.CrossRefPubMedGoogle Scholar
  51. 51.
    Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol. 2008;37:1316–25.CrossRefPubMedGoogle Scholar
  52. 52.
    Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case–control studies. PLoS One. Public Library of Science; 2013;8:e78071.Google Scholar
  53. 53.
    Natukula K, Jamil K, Pingali UR, Suresh Attili VS, Naidu Madireddy UR, Attili VSS, et al. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Nissar S, Lone TA, Banday MZ, Rasool R, Chowdri NA, Parray FQ, et al. Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: a case control study. Oncol Lett. 2013;5:959–63.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Saikia BJ, Phukan RK, Sharma SK, Sekhon SK, Mahanta J. Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India. Asian Pac J Cancer Prev. 2014;15:1993–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner EM, Kapp KS, et al. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol. 2011;98:387–93.CrossRefPubMedGoogle Scholar
  57. 57.
    Hoyos-Giraldo LS, Carvajal S, Cajas-Salazar N, Ruíz M, Sánchez-Gómez A. Chromosome aberrations in workers exposed to organic solvents: influence of polymorphisms in xenobiotic-metabolism and DNA repair genes. Mutat Res Fundam Mol Mech Mutagen. 2009;666:8–15.CrossRefGoogle Scholar
  58. 58.
    Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst. 2005;97:567–76.CrossRefPubMedGoogle Scholar
  59. 59.
    Hong YC, Lee KH, Kim WC, Choi SK, Woo ZH, Shin SK, et al. Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer. 2005;116:428–32.CrossRefPubMedGoogle Scholar
  60. 60.
    Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 2006;97:505–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis. 2006;21:115–23.CrossRefPubMedGoogle Scholar
  62. 62.
    Meng X, Liu Y, Liu B. Glutathione S-transferase M1 null genotype meta-analysis on gastric cancer risk. Diagn Pathol. 2014;9:122.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, et al. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233–6.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Chen B, Cao L, Zhou Y, Yang P, Wan H-W, Jia G-Q, et al. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci. 2010;55:1831–8.CrossRefPubMedGoogle Scholar
  65. 65.
    Dunna NR, Vuree S, Kagita S, Surekha D, Digumarti R, Rajappa S, et al. Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet. 2012;91:1–4.CrossRefGoogle Scholar
  66. 66.
    Srivastava DSL, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int. 2005;95:170–3.CrossRefPubMedGoogle Scholar
  67. 67.
    Maggini V, Buda G, Galimberti S, Martino A, Orciuolo E, Morabito F, et al. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk. Leuk Res. 2008;32:988–90.CrossRefPubMedGoogle Scholar
  68. 68.
    Bao LD, Niu JX, Song H, Wang Y, Ma RL, Ren XH, et al. Association between the GSTP1 codon 105 polymorphism and gastric cancer risk: an updated meta-analysis. Asian Pac J Cancer Prev. 2012;13:3687–93.CrossRefPubMedGoogle Scholar
  69. 69.
    Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, et al. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J Exp Ther Oncol. 2008;7:73–85.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2016

Authors and Affiliations

  • Soumee Ghosh
    • 1
  • Sudakshina Ghosh
    • 1
  • Biswabandhu Bankura
    • 1
  • Makhan Lal Saha
    • 3
  • Suvendu Maji
    • 3
  • Souvik Ghatak
    • 2
  • Arup Kumar Pattanayak
    • 1
  • Susanta Sadhukhan
    • 1
  • Manalee Guha
    • 1
  • Senthil Kumar Nachimuthu
    • 2
  • Chinmay Kumar Panda
    • 4
  • Biswanath Maity
    • 1
  • Madhusudan Das
    • 1
  1. 1.Department of ZoologyUniversity of CalcuttaKolkataIndia
  2. 2.Department of BiotechnologyMizoram UniversityAizawlIndia
  3. 3.Department of SurgeryInstitute of Post Graduate Medical Education & ResearchKolkataIndia
  4. 4.Department of Oncogene Regulation and Viral Associated Human CancerChittaranjan Cancer Research InstituteKolkataIndia

Personalised recommendations